Becker's Hospital Review

FDA clears AI imaging tool for brain metastases

The FDA has granted 510(k) clearance to Brain Mets, an AI-based software platform designed to aid in the detection, tracking and treatment planning of brain metastases. The tool, developed by Neosoma, ...
Hosted on MSN

Standardized criteria for amino acid PET imaging could improve diagnosis and treatment of brain metastases

Brain metastases often occur as a result of advanced cancer, and despite medical innovations, are still associated with a poor prognosis. Now, an international expert committee led by the Medical ...
ascopubs.org

Magnetic resonance imaging–based deep learning for predicting EGFR mutations in metastatic non-small cell lung cancer: A systematic review and meta-analysis.

Treatment modalities and survival outcomes in patients with hepatocellular carcinoma with brain metastases (HCC-BM): A large national study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
ascopubs.org

Automatic Abstraction of Computed Tomography Imaging Indication Using Natural Language Processing for Evaluation of Surveillance Patterns in Long-Term Lung Cancer Survivors

Development and Validation of a Simulation Model–Based Tool to Support Individualized Physical Activity Discussions and Prescriptions for Breast Cancer Survivors We used electronic health records of ...
Nasdaq

Moleculin Biotech Reports Promising Efficacy Results for Annamycin in Phase 1B/2 Trial for Soft Tissue Sarcoma Lung Metastases

Moleculin Biotech, Inc. announced promising results from their Phase 1B/2 trial of Annamycin for treating soft tissue sarcoma lung metastases, showing a robust clinical benefit rate of 59.4% among ...